SCHEMBL25539730

SCHEMBL25539730

CC1(C)c2cc3ccccc3cc2-c2cccc(-c3ccc(-c4nc(-c5ccccc5)cc(-c5ccc6c(c5)C(c5ccccc5)(c5ccccc5)c5ccccc5-6)n4)c4ccccc34)c21

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.34
MAPT P10636 4/20 0.34
KMT2A Q03164 4/20 0.34
ALDH1A1 P00352 3/20 0.34
HPGD P15428 3/20 0.34
KDM4E B2RXH2 3/20 0.34
LMNA P02545 3/20 0.34
GLA P06280 1/20 0.34
PDK2 Q15119 8/20 0.33
CYP1A1 P04798 1/20 0.33
CYP1B1 Q16678 1/20 0.33
ACACA Q13085 1/20 0.32
RARA P10276 1/20 0.32
RARB P10826 1/20 0.32
CTRC Q99895 1/20 0.31
OPRK1 P41145 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
PIM1 P11309 1/20 0.31
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25539731 0.97 MEN1 (0.33) MEN1MAPTKMT2AALDH1A1HPGD
SCHEMBL25537198 0.93 MEN1 (0.36) MEN1MAPTKMT2AALDH1A1HPGD
SCHEMBL25534572 0.93 MEN1 (0.34) MEN1MAPTKMT2AALDH1A1HPGD
SCHEMBL25539728 0.92 MAPT (0.31) MEN1MAPTKMT2AALDH1A1HPGD
SCHEMBL25538838 0.92 CYP1A1 (0.34) MEN1MAPTKMT2AALDH1A1HPGD
SCHEMBL25539713 0.91 MEN1 (0.37) MEN1MAPTKMT2AALDH1A1HPGD
SCHEMBL25537201 0.90 MEN1 (0.35) MEN1MAPTKMT2AALDH1A1HPGD
SCHEMBL25539732 0.90 LMNA (0.31) MEN1MAPTKMT2AALDH1A1HPGD
SCHEMBL25539720 0.90 MEN1 (0.34) MEN1MAPTKMT2AALDH1A1HPGD
SCHEMBL25539826 0.89 PDK2 (0.34) MEN1MAPTKMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM MEN1 267/4885MAPT 1595/4885KMT2A 1094/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.